Unexpected finding of AA amyloidosis with novel genetic variants in the MEFV gene in patients undergoing kidney biopsy for proteinuria. A case series.

J NephrolOct 22, 2026

Beyza Doğan, Süleyman Karaköse, Edip Erkuş et al.

✦ AI-curated · Sources linked

Case in brief

The report describes patients undergoing kidney biopsy for proteinuria in whom AA amyloidosis was identified, alongside MEFV gene variants. The abstract frames the cases as a spectrum of clinical presentations and diagnostic challenges, with variants beyond the well-recognised M694V mutation, including heterozygous and less common variants. It does not provide individual patient details, specific variants, treatments, or outcomes, so the diagnostic course and resolution cannot be described further.

What made this case unusual

AA amyloidosis was found during biopsy for proteinuria in patients carrying heterozygous or less common MEFV variants, rather than the focus being limited to the recognised M694V risk variant.

Diagnostic / clinical pearl

When AA amyloidosis is identified, consider the potential relevance of heterozygous or less common MEFV variants; the report highlights that these may be overlooked.

Source

Published in J Nephrol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Nephrology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.